Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 112.0 | 65 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 172.0 | 73 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 202.5 | 76 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 253.0 | 68 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 253.5 | 62 | |
N2759 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 333.0 | 47 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 188.0 | 79 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 213.0 | 53 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 253.0 | 66 | |
N2586 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 199.0 | 79 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 162.5 | 52 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | SCGF-b | 174.5 | 56 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 96.0 | 65 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | SCGF-b | 110.0 | 73 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 136.0 | 76 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | SCGF-b | 134.0 | 67 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | SCGF-b | 106.0 | 62 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | SCGF-b | 99.0 | 65 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 207.0 | 55 | ||||
RA1869 | 3 | SCGF-b | 185.0 | 54 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 121.0 | 78 | ||||
N2759 | 3 | SCGF-b | 121.0 | 63 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 158.0 | 60 | ||||
RA1931 | 3 | SCGF-b | 151.0 | 46 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | SCGF-b | 117.0 | 54 |